In 2010, the United States Drug Enforcement Administration (DEA) revised its regulations to allow pharmacies, hospitals, and health care providers to use electronic prescribing of controlled substances (EPCS) technology in all 50 states. The use of EPCS technology can help health care providers integrate prescription information into electronic health records (EHRs) more directly, while improving patient safety and reducing diversion and fraud. In October 2018, Congress passed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act to address the opioids crisis. The SUPPORT for Patients and Communities Act includes a provision requiring prescriptions for controlled substances covered by Medicare Part D to be transmitted electronically starting in 2021. This data brief explores the use of EPCS among Medicare Part D providers on the Surescripts Network from 2015 to 2016. We also present variation in EPCS use and the number of opioid claims prescribed by prescriber specialty and state.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)